VolitionRx Limited
VNRX
$0.566
-$0.024-4.07%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 474.50K | 395.80K | 171.50K | 244.00K | 165.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 474.50K | 395.80K | 171.50K | 244.00K | 165.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 474.50K | 395.80K | 171.50K | 244.00K | 165.20K |
| SG&A Expenses | 2.87M | 3.67M | 3.93M | 4.44M | 4.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.34M | 7.39M | 8.56M | 8.98M | 8.82M |
| Operating Income | -5.87M | -6.99M | -8.38M | -8.74M | -8.65M |
| Income Before Tax | -5.87M | -7.06M | -8.47M | -8.80M | -8.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.87M | -7.06M | -8.47M | -8.80M | -8.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 47.00K | 74.60K | 104.60K | 101.50K | 82.90K |
| Net Income | -5.82M | -6.99M | -8.37M | -8.70M | -8.37M |
| EBIT | -5.87M | -6.99M | -8.38M | -8.74M | -8.65M |
| EBITDA | -5.58M | -6.72M | -8.12M | -8.44M | -8.36M |
| EPS Basic | -0.07 | -0.08 | -0.10 | -0.11 | -0.11 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| EPS Diluted | -0.07 | -0.08 | -0.10 | -0.11 | -0.11 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 87.89M | 82.67M | 81.96M | 79.45M | 78.18M |
| Average Diluted Shares Outstanding | 87.89M | 82.67M | 81.96M | 79.45M | 78.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
